Cannabidiol (CBD), another compound from cannabis, has also garnered interest in cancer research. Unlike THC, CBD is non-psychoactive and is believed to have anti-inflammatory and analgesic properties. Some studies suggest that CBD may work synergistically with THC, enhancing its therapeutic effects while mitigating adverse reactions. However, more research is needed to fully understand their interaction and efficacy in cancer treatment.
